A redox-responsive specific theranostic agent was developed by the conjugation of photosensitizers with the tryptophan-containing GE11 peptide via a cleavable disulfide linker. It showed a potential utility for the target-cell-specific activatable fluorescence imaging and photodynamic therapy of triple-negative breast cancers.
J. Kim, Y. Won, S. Goh and Y. Choi, J. Mater. Chem. B, 2016, 4, 6787 DOI: 10.1039/C6TB01519K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Please wait while we load your content...
